Area of research
Genetics · Molecular Biology
Research interest
Research interests include Cancer research, Biology, Haematopoiesis, Cilium, Autosomal Recessive Polycystic Kidney Disease, and Polycystic kidney disease.
Potential Disease-Modifying Activity of Navtemadlin (KRT-232), a First-in-Class MDM2 Inhibitor, Correlates with Clinical Benefits in Relapsed/Refractory Myelofibrosis (MF)
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance
Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia
CDX2 Expression in Hematopoietic Stem Cells Represents a Novel Model of De Novo Leukemia
Mutations in DZIP1L, which encodes a ciliary-transition-zone protein, cause autosomal recessive polycystic kidney disease